Venture Associate Director, Immunology Therapeutics

InforCapital, partnership; New York (NY); Hybrid; USD 180,000 - 260,000; Full time

Job summary

Schrödinger seeks a Ventures Associate Director - Therapeutics to source, evaluate, and incubate early-stage biotech opportunities. You will bridge breakthrough science and commercial venture creation with a focus on immune pathways and inflammatory biology.

As part of our Therapeutics Group, you will leverage venture experience to assess data, IP, and development potential while engaging with academic leaders and clinical experts to validate hypotheses and feasibility across multiple programs.

Qualifications

• Scientific investor with a track record of high-impact, peer-reviewed publications.
• Deep expertise in immune pathways, inflammatory cascades, and inflammaging.

Responsibilities

• Perform rigorous, hypothesis-driven scientific diligence on early-stage mechanisms and stealth startups in immunology, autoimmune diseases, chronic inflammation, and age-related immune dysfunction.
• Critically evaluate preclinical data packages, mechanism-of-action validity, therapeutic differentiation, target tractability, and IP landscapes.
• Engage with key opinion leaders, academic principal investigators, and clinical experts to validate scientific theses and therapeutic feasibility.
• Track and map emerging paradigms across academic research institutions, tech transfer offices, and clinical advancements in immunology and inflammation.
• Source high-quality deal flow by building relationships across the biotech venture ecosystem.

Skills

Immunology

Autoimmune biology

Inflammation

Venture experience

Therapeutics

IP strategy

Drug development lifecycles

Job description

Schrödinger seeks a Ventures Associate Director - Therapeutics to source, evaluate, and incubate early-stage biotech opportunities. You will bridge breakthrough science and commercial venture creation with a focus on immune pathways and inflammatory biology.

As part of our Therapeutics Group, you will leverage venture experience to assess data, IP, and development potential while engaging with academic leaders and clinical experts to validate hypotheses and feasibility across multiple programs.